Actual strategies for neuroprotement in glaucoma

Announcement:

Glaucoma remains one of the most complex problems in ophthalmology, where traditional reduction of intraocular pressure is often insufficient to preserve visual functions. In this video, Professor Evgeny Alekseevich Egorov examines modern neuroprotection strategies, including innovative drug delivery methods and proven retinolamine and mexidol application schemes, which can significantly improve the prognosis for patients.

Main topics:

• Glaucoma today: a disease characterized by an increase in intraocular pressure beyond the tolerable level, which leads to glaucomatous optic neuropathy, optic atrophy and visual field defects. The main goal of treatment is to preserve visual functions and the patient's quality of life.
• The role of neuroprotection: reducing intraocular pressure does not guarantee stabilization of the glaucoma process. Complex therapy is necessary, including direct and indirect neuroprotection.
• Data on the clinical efficacy of neuroprotective therapy for glaucoma: when using the drug Mexidol , improvement in visual acuity, expansion of visual fields and improvement in electrophysiological parameters have been proven.

Clinical recommendations: Mexidol (ethylmethylhydroxypyridine succinate) is included in the therapy for primary open-angle and closed-angle glaucoma.

Key findings:

• Neuroprotection is an essential component of glaucoma treatment, especially when intraocular pressure is normalized.
• The use of neuroprotective therapy demonstrates stable positive results.
• Modern methods of drug delivery increase the effectiveness of therapy.

For whom: ophthalmologists, neurologists, general practitioners.

Practical value: The video provides treatment algorithms based on clinical guidelines and evidence, making it useful for the daily work of physicians.

This material is especially relevant for specialists working with patients with progressive glaucoma and looking for effective methods of preserving visual functions.